Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study-Reference-Cited by-同舟云学术

Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study

Published:2018-06-25 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Saad Anas M.,Turk Tarek,Al-Husseini Muneer J.,Abdel-Rahman Omar^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-4610-4.pdf

Reference31 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. https://doi.org/10.3322/caac.21442 .

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: a cancer journal for clinicians. 2016;66(1):7–30.

3. National Cancer Institute. Estimated new cancer cases and deaths for 2013. SEER (Surveillance Epidemiology and End Results) cancer statistics review. Available from: http://www.seer.cancer.gov .

4. De La Cruz M, Young AP, Ruffin MT. Diagnosis and management of pancreatic cancer. Am Fam Physician. 2014;89(8):626–32.

5. Mohammed S, George Van Buren I, Fisher WE. Pancreatic cancer: advances in treatment. World Journal of Gastroenterology: WJG. 2014;20(28):9354.

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Label-free differentiation of pancreatic pathologies from normal pancreas utilizing end-to-end three-dimensional multimodal networks on CT;Clinical Radiology;2024-09

2. Age-period-cohort analysis of global, regional, and national pancreatic cancer incidence, mortality, and disability-adjusted life years, 1990–2019;BMC Cancer;2024-08-28

3. Investigating the influence of taurochenodeoxycholic acid (TCDCA) on pancreatic cancer cell behavior: An RNA sequencing approach;Journal of Biotechnology;2024-08

4. Comparative Analysis of Complications Following Distal Resections for Neuroendocrine Tumors and Adenocarcinoma: Unveiling the Differences;Medical Science Monitor;2024-07-24

5. Clinical outcomes of liposomal irinotecan in patients with advanced pancreatic cancer previously treated with conventional irinotecan: A meta‐analysis of real‐world evidence;Cancer;2024-07-10